{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:01:24Z","timestamp":1785427284124,"version":"3.56.0"},"posted":{"date-parts":[[2026,6,30]]},"group-title":"Neuroscience","reference-count":26,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"award":["AG086096"],"award-info":[{"award-number":["AG086096"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is classically defined by amyloid and tau pathology and is accompanied by broad disruptions in proteostasis. Heat shock proteins (HSPs) help maintain proteostasis, yet mitochondrial chaperone systems remain comparatively underexplored in AD. Hsp60 and Hsp10 form a mitochondrial chaperonin complex that folds dozens of AD-implicated mitochondrial proteins, but this client network has not been evaluated as an integrated proteostasis axis in AD. It remains unknown whether Hsp60\/10 client proteins are selectively vulnerable across AD severity.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analyzed transcriptomic, proteomic, neuropathological, and cognitive data from the Religious Order Study and Memory and Aging Project (ROSMAP) to evaluate Hsp60\/10 client proteins in AD. We compared Hsp60\/10 clients with abundance-matched non-client mitochondrial proteins and tested differences across AD diagnostic groups and associations with Braak\/tau burden, cognitive outcomes, and network centrality. These evidence layers were integrated into a candidate prioritization framework.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Hsp60\/10 client abundance declined more strongly at the protein level than at the RNA level in late-stage AD. Compared with abundance-matched non-client mitochondrial proteins, Hsp60\/10 clients showed stronger late-stage protein abundance decline. Greater late-stage client decline was associated with higher Hsp60\/10 network centrality, defining a selectively vulnerable client subnetwork. Lower client abundance was associated with greater Braak\/tau burden and greater cognitive impairment. Integrated prioritization nominated mitochondrial translation and TCA\/pyruvate\/redox clients as high-priority candidates for mechanistic follow-up.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Together, these findings identify an Hsp60\/10 client-centered mitochondrial proteostasis axis spanning mitochondrial translation and TCA\/pyruvate\/redox metabolism that is associated with AD severity. These findings identify a novel potential axis warranting further investigation as a mechanistic link between mitochondrial dysfunction, proteostasis, and AD.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.06.25.734545","type":"posted-content","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:25:26Z","timestamp":1782851126000},"source":"Crossref","is-referenced-by-count":0,"title":["Mitochondrial Hsp60\/10 Client Protein Decline Reveals Braak\/Tau- and Cognition-Linked Proteostasis Vulnerabilities in Alzheimer\u2019s Disease"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2128-7907","authenticated-orcid":false,"given":"Ashlyn","family":"Sloane","sequence":"first","affiliation":[{"name":"Buck Institute for Research on Aging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4964-5208","authenticated-orcid":false,"given":"Varunya M.","family":"Kattunga","sequence":"additional","affiliation":[{"name":"Buck Institute for Research on Aging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1324-4875","authenticated-orcid":false,"given":"Julie K.","family":"Andersen","sequence":"additional","affiliation":[{"name":"Buck Institute for Research on Aging"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026070306300805000_2026.06.25.734545v1.1","unstructured":"Alzheimer\u2019s Association. 2025 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s & Dementia. 2025 Apr;21(4)."},{"key":"2026070306300805000_2026.06.25.734545v1.2","doi-asserted-by":"crossref","unstructured":"Sweeney P , Park H , Baumann M , Dunlop J , Frydman J , Kopito R , et al. Protein misfolding in neurodegenerative diseases: implications and strategies. Translational Neurodegeneration. 2017 Mar 13;6(1).","DOI":"10.1186\/s40035-017-0077-5"},{"key":"2026070306300805000_2026.06.25.734545v1.3","doi-asserted-by":"crossref","unstructured":"Lackie RE , Maciejewski A , Ostapchenko VG , Marques-Lopes J , Choy WY , Duennwald ML , et al. The Hsp70\/Hsp90 Chaperone Machinery in Neurodegenerative Diseases. Frontiers in Neuroscience. 2017 May 16;11.","DOI":"10.3389\/fnins.2017.00254"},{"key":"2026070306300805000_2026.06.25.734545v1.4","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-020-01080-6"},{"issue":"10","key":"2026070306300805000_2026.06.25.734545v1.5","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.3390\/ijms25105483","article-title":"Molecular Chaperonin HSP60: Current Understanding and Future Prospects","volume":"25","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"2026070306300805000_2026.06.25.734545v1.6","first-page":"47","article-title":"Heat shock protein 10 (Hsp10) in immune-related diseases: one coin, two sides","volume":"2","year":"2010","journal-title":"International Journal of Biochemistry and Molecular Biology"},{"issue":"9","key":"2026070306300805000_2026.06.25.734545v1.7","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.3390\/ijms19092603","article-title":"Heat Shock Proteins in Alzheimer\u2019s Disease: Role and Targeting","volume":"19","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"2026070306300805000_2026.06.25.734545v1.8","doi-asserted-by":"crossref","unstructured":"Larsson, JNK , Nystr\u00f6m S , Hammarstr\u00f6m P . HSP10 as a Chaperone for Neurodegenerative Amyloid Fibrils. Frontiers in Neuroscience. 2022 Jun 13;16.","DOI":"10.3389\/fnins.2022.902600"},{"key":"2026070306300805000_2026.06.25.734545v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-021-00999-y"},{"key":"2026070306300805000_2026.06.25.734545v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2013.02.059"},{"issue":"3","key":"2026070306300805000_2026.06.25.734545v1.11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3233\/JAD-230027","article-title":"Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer\u2019s Disease","volume":"95","year":"2023","journal-title":"Journal of Alzheimer s Disease"},{"key":"2026070306300805000_2026.06.25.734545v1.12","doi-asserted-by":"crossref","unstructured":"Wang M , Roussos P , McKenzie A , Zhou X , Kajiwara Y , Brennand KJ , et al. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer\u2019s disease. Genome Medicine. 2016 Nov 1;8(1).","DOI":"10.1186\/s13073-016-0355-3"},{"key":"2026070306300805000_2026.06.25.734545v1.13","doi-asserted-by":"crossref","first-page":"767560","DOI":"10.3389\/fnins.2021.767560","article-title":"Conditional Knockout of Pdha1 in Mouse Hippocampus Impairs Cognitive Function: The Possible Involvement of Lactate","volume":"15","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"4","key":"2026070306300805000_2026.06.25.734545v1.14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbrc.2017.05.162","article-title":"Alteration of mitochondrial protein PDHA1 in Lewy body disease and PARK14","volume":"489","year":"2017","journal-title":"Biochemical and biophysical research communications"},{"key":"2026070306300805000_2026.06.25.734545v1.15","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410170505"},{"key":"2026070306300805000_2026.06.25.734545v1.16","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410130116"},{"issue":"7","key":"2026070306300805000_2026.06.25.734545v1.17","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.celrep.2020.01.060","article-title":"Defective Mitochondrial Pyruvate Flux Affects Cell Bioenergetics in Alzheimer\u2019s Disease-Related Models","volume":"30","year":"2020","journal-title":"Cell Reports"},{"issue":"20","key":"2026070306300805000_2026.06.25.734545v1.18","doi-asserted-by":"crossref","first-page":"12403","DOI":"10.3390\/ijms232012403","article-title":"The \u03b1-Ketoglutarate Dehydrogenase Complex as a Hub of Plasticity in Neurodegeneration and Regeneration","volume":"23","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"2026070306300805000_2026.06.25.734545v1.19","doi-asserted-by":"crossref","unstructured":"Ahmad W , Ebert PR . Suppression of a core metabolic enzyme dihydrolipoamide dehydrogenase (dld) protects against amyloid beta toxicity in C. elegans model of Alzheimer\u2019s disease. Genes & Diseases. 2020 Aug;","DOI":"10.1016\/j.gendis.2020.08.004"},{"issue":"1","key":"2026070306300805000_2026.06.25.734545v1.20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12944-023-01918-9","article-title":"Identification of key lipid metabolism-related genes in Alzheimer\u2019s disease","volume":"22","year":"2023","journal-title":"Lipids in health and disease"},{"key":"2026070306300805000_2026.06.25.734545v1.21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mito.2020.05.012","article-title":"Alzheimer\u2019s and Parkinson\u2019s brain tissues have reduced expression of genes for mtDNA OXPHOS Proteins, mitobiogenesis regulator PGC-1\u03b1 protein and mtRNA stabilizing protein LRPPRC (LRP130)","volume":"53","year":"2020","journal-title":"Mitochondrion"},{"key":"2026070306300805000_2026.06.25.734545v1.22","doi-asserted-by":"crossref","unstructured":"Mandal P , Trushina E , Arnold M , Kaddurah-Daouk R , Baloni P . Mitochondrial bioenergetic signatures differentiate asymptomatic from symptomatic Alzheimer\u2019s disease. Communications Biology. 2026 Jun 10 [cited 2026 Jun 15].","DOI":"10.1038\/s42003-026-10474-8"},{"issue":"7","key":"2026070306300805000_2026.06.25.734545v1.23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/biology12070972","article-title":"Mitochondrial Neurodegenerative Diseases: Three Mitochondrial Ribosomal Proteins as Intermediate Stage in the Pathway That Associates Damaged Genes with Alzheimer\u2019s and Parkinson\u2019s","volume":"12","year":"2023","journal-title":"Biology"},{"issue":"5","key":"2026070306300805000_2026.06.25.734545v1.24","doi-asserted-by":"crossref","first-page":"e21445","DOI":"10.1096\/fj.202002461R","article-title":"TUFM is involved in Alzheimer\u2019s disease-like pathologies that are associated with ROS","volume":"35","year":"2021","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"12","key":"2026070306300805000_2026.06.25.734545v1.25","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.3390\/ijms25126452","article-title":"Mizoribine Promotes Molecular Chaperone HSP60\/HSP10 Complex Formation","volume":"25","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"2026070306300805000_2026.06.25.734545v1.26","doi-asserted-by":"crossref","unstructured":"Mayeri Z , Woods G , Rane A , Kifle A , Chamoli M , Shukla S , et al. A compound enhancing lysosomal function reduces tau pathology, microglial reactivity and rescues working memory in 3xTg AD mice. GeroScience. 2026 Mar 6;","DOI":"10.1007\/s11357-026-02139-5"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.25.734545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:30:52Z","timestamp":1783085452000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.06.25.734545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":26,"URL":"https:\/\/doi.org\/10.64898\/2026.06.25.734545","relation":{},"subject":[],"published":{"date-parts":[[2026,6,30]]},"subtype":"preprint"}}